HOME >> BIOLOGY >> NEWS
Computer modeling targets epidemics, bioterror

A new initiative harnesses our nation's computing skill to enhance our ability to respond to disease epidemics and bioterrorism. The initiative, called MIDAS, will develop powerful computer modeling techniques to analyze and respond to infectious disease outbreaks, whether they occur naturally, such as SARS, or are released intentionally in a bioterrorist attack. MIDAS (an acronym for Models of Infectious Disease Agent Study) is sponsored by the National Institute of General Medical Sciences (NIGMS), a part of the National Institutes of Health (NIH) that has a strong interest in bioinformatics and computational biology.

NIGMS recently awarded the first four grants in this new initiative, totaling more than $28 million over five years. Three of these grants will support the creation of mathematical models to study various aspects of infectious disease epidemics and community responses. These research grants together total $9.5 million over five years (averaging more than $640,000 per grant for the first year). A fourth award, totaling $18.8 million over five years ($3 million for the first year), funds researchers to develop a central database to organize information from the other three groups. It also supports the development of user-friendly computer modeling tools for the broader scientific community, policy makers and public health officials to use to simulate epidemics and response strategies.

"MIDAS will play a key role in the NIH biodefense plan," said Elias A. Zerhouni, M.D., NIH director. "The computer models created through this initiative will help us determine the best strategies to detect, control and prevent the spread of disease."

MIDAS will bring together interdisciplinary teams of scientists with expertise ranging from mathematics and computer science to epidemiology, genetics, and public health. The network of MIDAS scientists will be guided by a steering committee of investigators with broad expertise in modeling, infect
'"/>

Contact: Alisa Zapp Machalek
alisa.machalek@nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences
4-May-2004


Page: 1 2 3 4

Related biology news :

1. Computer scientists at UH developing nurturing computers
2. Computer models expose humans as main cause of caribou decline
3. Computer database being developed at Temple will allow for better inventory of chemicals
4. Computer imaging of Archeopteryx skull suggests this dinosaur-bird link could fly
5. Computer model shows increased US threat from soybean rust
6. 20 May AAAS lecture: Computers that Respond to Human Emotion
7. Computer method identifies potentially active enzymes
8. Computer scientists develop tool for mining genomic data
9. Computer model offers new tool to probe Woburn toxic waste site
10. Computer models forecast sharp increase in temperature if heat-trapping emissions continue to rise
11. Computer scientist locates more than 1,000 novel genes in mouse and human

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... , ... August 25, 2020 ... ... biotechnology company developing novel pharmaceuticals targeting mitochondria, in partnership with Essex Bio-Technology, ... in its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic solution ...
(Date:8/21/2020)... ... 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application ... COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 study ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based in Basel, ... license agreements with Housey Pharma’s HMI subsidiary to gain access to its core-enabling ... Research and Development spending in excess of US $10 billion. , Scientists at ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Slone Partners , ... announced the placement of Julianne Averill , CPA, as Chief Financial Officer ... operations and implementing key business strategies to accelerate Alveo’s growth as the company ...
(Date:8/15/2020)... ... August 13, 2020 , ... True Terpenes , the leading ... Scientific Advisory Board (SAB) to research the medical potential of terpenes and the potential ... combined with terpenes. The board is focused on expanding the recently launched line of ...
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD Society announced ... Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration of follow-on ... consortium of academic research centers in the United States and Europe with expertise ...
(Date:8/12/2020)... Mich. (PRWEB) , ... August 12, 2020 , ... ... Group, Inc. (EMMA International), a global leader in FDA compliance consulting has ... the nation’s fastest-growing private companies. The list represents a unique look at the ...
Breaking Biology Technology:
Cached News: